We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. The Administrator of personal data is STOCKTRADEIQ sp. z o.o., with its registered office in Poznan (61-625), at the following address: Czarna Rola 30 Street. Cookies policy here. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

  • Cookie
    cookieyes-consent
  • Duration
    1 year
  • Description
    CookieYes sets this cookie to remember users' consent preferences so that their preferences are respected on their subsequent visits to this site. It does not collect or store any personal information of the site visitors.
  • Cookie
    x-ms-cpim-csrf
  • Duration
    session
  • Description

    Inter-site request forgery token used to protect crSF. For more information, read the section Token falsification of requests between sites.

  • Cookie
    x-ms-cpim-sso:stocktradeiqauth.onmicrosoft.com_0
  • Duration
    session
  • Description

    Used to support single sign-on sessions. This cookie is set as persistent when the Keep me logged in option is enabled.

  • Cookie
    server-telemetry-{id}
  • Duration
    persistent
  • Description

    A value used by Microsoft for authorisation and authentication.

  • Cookie
    google_auto_fc_cmp_setting
  • Duration
    persistent
  • Description


    Stores the state of the User cookie for the current domain.

     

  • Cookie
    {id}-https://stocktradeiqauth.onmicrosoft.com/{id}
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    msal{id}.active-account
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    {id}signinup{id}stocktradeiqauth.b2clogin.com-refreshtoken
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    {id}signinup{id}stocktradeiqauth.b2clogin.com-idtoken
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    {id}signinup{id}stocktradeiqauth.b2clogin.com
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    Microsoft Clarity
  • Duration
    1 year
  • Description

    Microsoft Clarity

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

  • Cookie
    isLightMode
  • Duration
    1 year
  • Description

    Defines the UI theme

  • Cookie
    userCultureData
  • Duration
    persistent
  • Description

     Stores information about the user's machine culture.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

  • Cookie
    _ga
  • Duration
    1 year 1 month 4 days
  • Description
    The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
  • Cookie
    _ga_*
  • Duration
    1 year 1 month 4 days
  • Description
    Google Analytics sets this cookie to store and count page views.
  • Cookie
    hotjar
  • Duration
    1 year 1 month 4 days
  • Description

    Analyzing users' behaviour in the website

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

  • Cookie
    __gpi
  • Duration
    1 year 24 days
  • Description
    Google Ads Service uses this cookie to collect information about from multiple websites for retargeting ads.
  • Cookie
    __gads
  • Duration
    1 year 24 days
  • Description

    The file, set by Google, is stored in the DoubleClick domain and tracks the number of times users view an ad, measures the success of the campaign and calculates its revenue. This cookie can only be read from the domain where it is set and does not track any data when browsing other sites.

  • Cookie
    goog:cached:topics
  • Duration
    persistent
  • Description

    It is used to record which adverts have been displayed to the User.

  • Cookie
    IDE
  • Duration
    year
  • Description

    Used by Google DoubleClick to record and report on the Website User's actions after viewing or clicking on an advertiser's ads in order to measure the effectiveness of the ad and present the User with targeted advertising.

  • Cookie
    google_experiment_mod44
  • Duration
    persistent
  • Description

    Used by Google Ad to experiment with the effectiveness of ads on websites using their services.

Powered by Cookieyes logo

    Get Diamond plan for FREE

    logo

    bioAffinity Technologies, Inc. (BIAFW)

    Price:

    0.52 USD

    ( + 0.29 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    BIAFW
    Name
    bioAffinity Technologies, Inc.
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare
    Price
    0.523
    Market Cap
    41.676M
    Enterprise value
    11.434M
    Currency
    USD
    Ceo
    Maria Zannes
    Full Time Employees
    57
    Website
    bioaffinitytech.com
    Ipo Date
    City
    San Antonio
    Address
    3300 Nacogdoches Road

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    IDEXX Laboratories, Inc.

    VALUE SCORE:

    8

    Symbol
    IDXX
    Market Cap
    50.535B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare

    2nd position

    GRAIL, Inc.

    VALUE SCORE:

    9

    Symbol
    GRAL
    Market Cap
    2.593B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare

    The best

    Medpace Holdings, Inc.

    VALUE SCORE:

    9

    Symbol
    MEDP
    Market Cap
    14.946B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -0.209
    P/S
    0.373
    P/B
    -1.143
    Debt/Equity
    -0.314
    EV/FCF
    -0.352
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    0.356
    Earnings yield
    -4.786
    Debt/assets
    0.141
    FUNDAMENTALS
    Net debt/ebidta
    0.012
    Interest coverage
    -138.576
    Research And Developement To Revenue
    0.221
    Intangile to total assets
    0.453
    Capex to operating cash flow
    -0.010
    Capex to revenue
    0.010
    Capex to depreciation
    0.129
    Return on tangible assets
    -4.495
    Debt to market cap
    0.234
    Piotroski Score
    2.000
    FUNDAMENTALS
    PEG
    -0.074
    P/CF
    -0.314
    P/FCF
    -0.365
    RoA %
    -246.024
    RoIC %
    -401.714
    Gross Profit Margin %
    29.868
    Quick Ratio
    0.628
    Current Ratio
    0.645
    Net Profit Margin %
    -152.168
    Net-Net
    -7.176
    FUNDAMENTALS PER SHARE
    FCF per share
    -9.678
    Revenue per share
    9.593
    Net income per share
    -14.598
    Operating cash flow per share
    -9.586
    Free cash flow per share
    -9.678
    Cash per share
    1.003
    Book value per share
    -2.668
    Tangible book value per share
    -5.353
    Shareholders equity per share
    -2.668
    Interest debt per share
    0.927
    TECHNICAL
    52 weeks high
    0.788
    52 weeks low
    0.410
    Current trading session High
    0.788
    Current trading session Low
    0.410
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo
    Country
    US
    Sector
    Technology
    Industry
    Communication Equipment
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.982
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    -105.05823000000001%
    P/E
    -0.087
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.221
    logo
    Country
    US
    Sector
    Financial Services
    Industry
    Shell Companies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.229
    logo
    Country
    US
    Sector
    Industrials
    Industry
    Specialty Business Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.840
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.425
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -13.610
    DESCRIPTION

    bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

    NEWS
    https://images.financialmodelingprep.com/news/bioaffinity-technologies-adds-to-growing-number-of-case-studies-demonstrating-20250926.jpg
    bioAffinity Technologies Adds to Growing Number of Case Studies Demonstrating Clinical Value of CyPath® Lung

    https://www.businesswire.com

    2025-09-26 08:00:00

    bioAffinity Technologies shares 3 new case studies in which CyPath Lung detected Stage 1A lung cancer or prevented unnecessary invasive procedures.